Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: Determining clinical markers and exploring social pathways

References

• Anis , A.H. , Guh , D. , Hogg , R.S. , Wang , X.H. , Yip , B. Craib , K.J.P. 2000 . The cost-effectiveness of antiretroviral regimens for the treatment of HIV/AIDS . Pharmacoeconomics , 18 : 393 – 404 .
   PubMed Web of Science ®Google Scholar
• Anis , A.H. , Hogg , R.S. , Wang , X.H. , Yip , B. , Palepu , A. Montaner , J.S. 1998 . Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy . Pharmacoeconomics , 13 : 697 – 705 .
   PubMed Web of Science ®Google Scholar
• Bogart , L.M. , Kelly , J.A. , Catz , S.L. and Sosman , J.M. 2000 . Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment . Journal of AIDS , 23 : 396 – 404 .
   PubMed Web of Science ®Google Scholar
• Braitstein , P. , Li , K. , Tyndall , M. , Spittal , P. , O'Shaughnessy , M.V. Schilder , A. 2003 . Sexual violence among a cohort of injection drug users . Social Science and Medicine , 57 : 561 – 569 .
   PubMed Web of Science ®Google Scholar
• Chamberlayne , R. , Green , B. , Barer , M.L. , Hertzman , C. , Lawrence , W.J. and Sheps , S.B. 1998 . Creating a population-based linked health database: A new resource for health services research . Canadian Journal of Public Health , 89 : 270 – 273 .
   PubMed Web of Science ®Google Scholar
• Chan , K.C. , Yip , B. , Hogg , R.S. , Montaner , J.S. and O'Shaughnessy , M.V. 2002 . Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States . AIDS , 16 : 1693 – 1695 .
   PubMed Web of Science ®Google Scholar
• Detels , R. , Tarwater , P. , Phair , J.P. , Margolick , J. , Riddler , S.A. Munoz , A. 2001 . Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis . AIDS , 15 : 347 – 355 .
   PubMed Web of Science ®Google Scholar
• Egger , M. , May , M. , Chene , G. , Phillips , A.N. , Ledergerber , B. Dabis , F. 2002 . Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies . Lancet , 360 : 119 – 129 .
   PubMed Web of Science ®Google Scholar
• Floris-Moore , M. , Lo , Y. , Klein , R.S. , Budner , N. , Gourevitch , M.N. Moskaleva , G. 2003 . Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy . Journal of AIDS , 34 : 331 – 337 .
   PubMed Web of Science ®Google Scholar
• Freedberg , K.A. , Losina , E. , Weinstein , M.C. , Paltiel , A.D. , Cohen , C.J. Seage , G.R. 2001 . The cost effectiveness of combination antiretroviral therapy for HIV disease . New England Journal of Medecine , 344 : 824 – 831 .
   PubMed Web of Science ®Google Scholar
• French , M.A. , Price , P. and Stone , S.F. 2004 . Immune restoration disease after antiretroviral therapy . AIDS , 18 : 1615 – 1627 .
   PubMed Web of Science ®Google Scholar
• Galai , N. , Vlahov , D. , Bareta , J.C. , Wang , C. , Cohn , S. and Sterling , T.R. 2005 . Prognostic factors for survival differ according to CD4 cell count among HIV-infected injection drug users: Pre-HAART and HAART eras . Journal of AIDS , 38 : 74 – 81 .
   PubMed Web of Science ®Google Scholar
• Gardner , L.I. , Klein , R.S. , Szczech , L.A. , Phelps , R.M. , Tashima , K. Rompalo , A.M. 2003 . Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women . Journal of AIDS , 34 : 320 – 330 .
   PubMed Web of Science ®Google Scholar
• Gebo , K.A. , Diener-West , M. and Moore , R.D. 2001 . Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy . Journal of AIDS , 27 : 143 – 152 .
   PubMed Web of Science ®Google Scholar
• Gebo , K.A. , Diener-West , M. and Moore , R.D. 2003 . Hospitalization rates differ by hepatitis C status in an urban HIV cohort . Journal of AIDS , 34 : 165 – 173 .
   PubMed Web of Science ®Google Scholar
• Heath , K.V. , Cornelisse , P.G. , Strathdee , S.A. , Palepu , A. , Miller , M.L. Schechter , M.T. 1999 . HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men . International Journal of STD and AIDS , 10 : 582 – 587 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Craib , K.J. , Willoughby , B. , Sestak , P. , Montaner , J.S. and Schechter , M.T. 1993 . Sociodemographic correlates for risk-taking behaviour among HIV seronegative homosexual men . Canadian Journal of Public Health , 84 : 423 – 426 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Schechter , M.T. , Schilder , A. , Le , R. , Strathdee , S.A. Goldstone , I.L. 1995 . Access to healthcare and geographic mobility of HIV/AIDS patients . AIDS Patient Care , 9 : 297 – 302 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Yip , B. , Chan , K.J. , Wood , E. , Craib , K.J. O'Shaughnessy , M.V. 2001 . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy . Journal Of The American Medical Association , 286 : 2568 – 2577 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Yip , B. , Kully , C. , Craib , K.J. , O'Shaughnessy , M.V. Schechter , M.T. 1999 . Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens . Canadian Medical Association Journal , 160 : 659 – 665 .
   PubMed Web of Science ®Google Scholar
• Holmberg , S.D. , Palella , F.J. Jr , Lichtenstein , K.A. and Havlir , D.V. 2004 . The case for earlier treatment of HIV infection . Clinical Infectious Diseases , 39 : 1699 – 1704 .
   PubMed Web of Science ®Google Scholar
• Kerr , T. , Wood , E. , Grafstein , E. , Ishida , T. , Shannon , K. Lai , C. 2005 . High rates of primary care and emergency department use among injection drug users in Vancouver . Journal of Public Health , 27 : 62 – 66 .
   PubMed Web of Science ®Google Scholar
• Krentz , H.B. , Auld , M.C. and Gill , M.J. 2004 . The high cost of medical care for patients who present late (CD4 < 20 cells/mL) with HIV infection . HIV Medicine , 5 : 93 – 98 .
   PubMed Web of Science ®Google Scholar
• Kuyper , L.M. , Hogg , R.S. , Montaner , J.S. , Schechter , M.T. and Wood , E. 2004 . The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions . Journal of Urban Health , 81 : 655 – 660 .
   PubMed Web of Science ®Google Scholar
• Manavi , K. , McMillan , A. , Ogilvie , M. and Scott , G. 2004 . Heterosexual men and women with HIV test positive at a later stage of infection than homo or bisexual men . International Journal of STD and AIDS , 15 : 811 – 814 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Ledergerber , B. , Katlama , C. , Kirk , O. , Reiss , P. Monforte , A.D. 2003 . Decline in the AIDS and death rates in the EuroSIDA study: An observational study . Lancet , 362 : 22 – 29 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Monforte , A. , Kirk , O. , Johnson , M.A. , Friis-Moller , N. Banhegyi , D. 2004 . Changes in hospital admissions across Europe: 1995–2003. Results from the EuroSIDA study . HIV Medicine , 5 : 437 – 447 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Vella , S. , Benfield , T.L. , Chiesi , A. , Miller , V. Gargalianos , P. 1998 . Changing patterns of mortality across Europe in patients infected with HIV-1 . Lancet , 352 : 1725 – 1730 .
   PubMed Web of Science ®Google Scholar
• Mouton , Y. , Alfandari , S. , Valette , M. , Cartier , F. , Dellamonica , P. Humbert , G. 1997 . Impact of protease inhibitors on AIDS-defining events and hospitalizations in ten French AIDS reference centres . AIDS , 11 : F101 – F105 .
   PubMed Web of Science ®Google Scholar
• Palella , F.J. , Delaney , K.M. , Moorman , A.C. , Loveless , M.O. , Fuhrer , J. Satten , G.A. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection . New England Journal of Medecine , 338 : 853 – 860 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Strathdee , S.A. , Hogg , R.S. , Anis , A.H. , Rae , S. Cornelisse , P.G. 1999 . The social determinants of emergency department and hospital use by injection drug users in Canada . Journal of Urban Health , 76 : 409 – 418 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Tyndall , M.W. , Leon , H. , Muller , J. , O'Shaughnessy , M.V. Schechter , M.T. 2001 . Hospital utilization and costs in a cohort of injection drug users . Canadian Medical Association Journal , 165 : 415 – 420 .
   PubMed Web of Science ®Google Scholar
• Paul , S. , Gilbert , H.M. , Ziecheck , W. , Jacobs , O. and Sepkowitz , K.A. 1999 . The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection . AIDS , 13 : 415 – 418 .
   PubMed Web of Science ®Google Scholar
• Pulvirenti , J.J. , Glowacki , R. , Muppiddi , U. , Surapaneni , N. , Gail , C. Kohl , B. 2003 . Hospitalized HIV-infected patients in the HAART era: A view from the inner city . AIDS Patient Care STDs , 17 : 565 – 573 .
   PubMed Web of Science ®Google Scholar
• Rusch , M. , Nixon , S. , Schilder , A. , Braitstein , P. , Chan , K. and Hogg , R.S. 2004 . Use of antiretroviral therapy among HIV-positive individuals living in British Columbia . AIDS Care , 16 : 914 – 922 .
   PubMed Web of Science ®Google Scholar
• Sabin , C.A. , Smith , C.J. , Gumley , H. , Murphy , G. , Lampe , F.C. Phillips , A.N. 2004 . Late presenters in the era of highly active antiretroviral therapy: Uptake of and responses to antiretroviral therapy . AIDS , 18 : 2145 – 2151 .
   PubMed Web of Science ®Google Scholar
• Shapiro , M.F. , Morton , S.C. , McCaffrey , D.F. , Senterfitt , J.W. , Fleishman , J.A. Perlman , J.F. 1999 . Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study . Journal of the American Medical Association , 281 : 2305 – 2315 .
   PubMed Web of Science ®Google Scholar
• Shelburne , S.A. , Visnegarwala , F. , Darcourt , J. , Graviss , E.A. , Giordano , T.P. White , A.C.J. 2005 . Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy . AIDS , 19 : 399 – 406 .
   PubMed Web of Science ®Google Scholar
• Sterling , T.R. , Chaisson , R.E. , Keruly , J. and Moore , R.D. 2003 . Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: Longer follow-up of an observational cohort study . Journal of Infectious Diseases , 188 : 1659 – 1665 .
   PubMed Web of Science ®Google Scholar
• Strathdee , S.A. , Palepu , A. , Cornelisse , P.G. , Yip , B. , O'Shaughnessy , M.V. Montaner , J.S. 1998 . Barriers to use of free antiretroviral therapy in injection drug users . Journal of the American Medical Association , 280 : 547 – 549 .
   PubMed Web of Science ®Google Scholar
• Tarwater , P.M. , Gallant , J.E. , Mellors , J.W. , Gore , M.E. , Phair , J.P. Detels , R. 2004 . Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users . AIDS , 18 : 2419 – 2423 .
   PubMed Web of Science ®Google Scholar
• Tashima , K.T. , Hogan , J.W. , Gardner , L.I. , Korkontzelou , C. , Schoenbaum , E.E. Schuman , P. 2001 . A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use . Clinical Infectious Diseases , 33 : 2055 – 2060 .
   PubMed Web of Science ®Google Scholar
• Weber , A.E. , Chan , K. , George , C. , Hogg , R.S. , Remis , R.S. Martindale , S. 2001 . Risk factors associated with HIV infection among young gay and bisexual men in Canada . Journal of AIDS , 28 : 81 – 88 .
   PubMed Web of Science ®Google Scholar
• Wohl , A.R. , Lu , S. , Odem , S. , Sorvillo , F. , Pegues , C.F. and Kerndt , P.R. 1998 . Sociodemographic and behavioral characteristics of African-American women with HIV and AIDS in Los Angeles County, 1990–1997 . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology , 19 : 413 – 420 .
   PubMedGoogle Scholar
• Wood , E. , Hogg , R.S. , Yip , B. , Harrigan , P.R. and Montaner , J.S. 2004a . Earlier initiation of highly active antiretroviral therapy does not protect against the deleterious effects of non-adherence . AIDS , 18 : 2432 – 2434 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Hogg , R.S. , Yip , B. , Harrigan , P.R. , O'Shaughnessy , M.V. and Montaner , J.S. 2003a . Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4 + cell count is 0.200 to 0.350×10(9) cells/L . Annals of Internal Medicine , 139 : 810 – 816 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Hogg , R.S. , Yip , B. , Harrigan , P.R. , O'Shaughnessy , M.V. and Montaner , J.S. 2004b . The impact of adherence on CD4 cell count responses among HIV-infected patients . Journal of AIDS , 35 : 261 – 268 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Chan , K. , Tyndall , M.W. , Schechter , M.T. Bangsberg , D. 2002 . Socioeconomic status, access to triple therapy and survival from HIV-disease since 1996 . AIDS , 16 : 2065 – 2072 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Yip , B. , Tyndall , M.W. , Schechter , M.T. O'Shaughnessy , M.V. 2003b . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users . Canadian Medical Association Journal , 169 : 656 – 661 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Yip , B. , Hogg , R.S. , Sherlock , C.H. , Jahnke , N. Harrigan , R.P. 2000 . Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy . AIDS , 14 : 1955 – 1960 .
   PubMed Web of Science ®Google Scholar
• Yeni , P.G. , Hammer , S.M. , Hirsch , M.S. , Saag , M.S. , Schechter , M. Carpenter , C.C.J. 2004 . Treatment for adult HIV infection: 2004 recommendations of the international AIDS society-USA panel . Journal of the American Medical Association , 292 : 251 – 265 .
   PubMed Web of Science ®Google Scholar